Microbiome in reflux disorders and esophageal adenocarcinoma

Cancer Journal (United States)

Volumn 20, Issue 3, 2014, Pages 207-210

  Yang, Liying ^a   Chaudhary, Noami ^a   Baghdadi, Jonathan ^a   Pei, Zhiheng ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

16S rRNA gene; Barrett esophagus adenocarcinoma; cancer; GERD; inflammation; microbiome; reflux esophagitis; risk factors; sequencing

Indexed keywords

BACTERIAL COLONIZATION; BACTEROIDETES; BARRETT ESOPHAGUS; CAMPYLOBACTER; CARCINOGENESIS; DYSBIOSIS; ENTERITIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS FLORA; FIRMICUTES; FUSOBACTERIA; FUSOBACTERIUM; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIAL COMMUNITY; MICROBIOME; NEISSERIA; NONHUMAN; PATHOGENESIS; PERIODONTAL DISEASE; PRECANCER; PREVOTELLA; PRIORITY JOURNAL; PROTEOBACTERIA; REFLUX ESOPHAGITIS; REVIEW; SPIROCHETE; STREPTOCOCCUS; TUMOR BIOPSY; VEILLONELLA; ADENOCARCINOMA; ESOPHAGUS TUMOR; MICROBIOLOGY; MICROFLORA;

ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL REFLUX; HUMANS; MICROBIOTA;

EID: 84901492376     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0000000000000044     Document Type: Review

References (35)

1. Pohl H, Sirovich B,Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev. 2010;19:1468-1470.
2. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831. (Pubitemid 29142625)
3. Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut. 2005;54(suppl 1):i1-i5. (Pubitemid 40293002)
4. Anderson LA, Murphy SJ, Johnston BT, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut. 2008;57:734-739. (Pubitemid 351716963)
5. Rieder F, Biancani P, Harnett K, et al. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2010;298:G571-G581.
6. Reid BJ, Li X, Galipeau PC, et al. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 2010;10:87-101.
7. Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404-1413. (Pubitemid 37220460)
8. Pei Z, Bini EJ, Yang L, et al. Bacterial biota in the human distal esophagus. Proc Natl Acad Sci USA. 2004;101:4250-4255. (Pubitemid 38405915)
9. Pei Z, Yang L, Peek RM, et al. Bacterial biota in reflux esophagitis and Barrett's esophagus. World J Gastroenterol. 2005;11:7277-7283. (Pubitemid 43137676)
10. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-1118. (Pubitemid 32440925)
11. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134: 577-594. (Pubitemid 351173057)
12. Yang L, Francois F, Pei Z. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett's esophagus. Clin Cancer Res. 2012;18:2138-2144.
13. Yang L, Lu X, Nossa CW, et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009;137:588-597.
14. Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature 2006;444:1022-1023. (Pubitemid 46018512)
15. Macfarlane S, Furrie E, Macfarlane G, et al. Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. Clin Infect Dis. 2007:45:29-38. (Pubitemid 46984612)
16. Blackett KL, Siddhi SS, Cleary S, et al. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality. Aliment Pharmacol Ther. 2013;37:1084-1092.
17. Narikiyo M, Tanabe C, Yamada Y, et al. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci. 2004;95:569-574. (Pubitemid 39089637)
18. Liu N, Ando T, Ishiguro K, et al. Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett's esophagus. BMC Infect Dis. 2013;13:130.
19. Lau WF, Wong J, Lam KH, et al. Oesophageal microbial flora in carcinoma of the oesophagus. Aust N Z J Surg. 1981;51:52-55. (Pubitemid 11096065)
20. Finlay IG, Wright PA, Menzies T, et al. Microbial flora in carcinoma of oesophagus. Thorax. 1982:37:181-184. (Pubitemid 12154573)
21. Mannell A, Plant M, Frolich J. The microflora of the oesophagus. Ann R Coll Surg Engl. 1983;65:152-154. (Pubitemid 13091396)
22. Gagliardi D, Makihara S, Corsi PR, et al. Microbial flora of the normal esophagus. Dis Esophagus. 1998;11:248-250. (Pubitemid 29087927)
23. Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192:5002-5017.
24. Oliver JD. Recent findings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol Rev. 2010;34:415-425.
25. Nossa CW, Tang Y-W, Pei Z. Pearls and pitfalls of genomics based microbiome analysis. Emerg Microbes Infect. 2012;1:e45.
26. Woese CR. Bacterial evolution. Microbiol Rev. 1987;51:221-271. (Pubitemid 17082512)
27. Stackebrandt E. Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology. Int J Syst Bacteriol. 1994;44:846-849. (Pubitemid 24315169)
28. Pei AY, Oberdorf WE, Nossa CW, et al. Diversity of 16S rRNA genes within individual prokaryotic genomes. Appl EnvironMicrobiol. 2010;76:3886-3897.
29. Osias GL, Bromer MQ, Thomas RM, et al. Esophageal bacteria and Barrett's esophagus: a preliminary report. Dig Dis Sci. 2004;49:228-236. (Pubitemid 38392222)
30. Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther. 2000;14:729-735. (Pubitemid 30352739)
31. Peek RM. Helicobacter pylori and gastroesophageal reflux disease. Curr Treat Options Gastroenterol. 2004;7:59-70.
32. Yang L, Oberdorf W, Gerz E, et al. Foregut microbiome in development of esophageal adenocarcinoma. Nature Proceedings. 2010. Available at: http://dx.doi.org/10.1038/npre.2010.5026.1. Accessed April 1, 2014.
33. IH HMP Working Group, Peterson J, Garges S, Giovanni M, et al. The NIH Human Microbiome Project. Genome Res. 2009;19:2317-2323.
34. Hayes RB, Reding D, Kopp W, et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials. 2000;21:349S-355S.
35. Calle EE, Rodriguez C, Jacobs EJ, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 2002;94:500-511. (Pubitemid 34081382)